#Genotypic and Predicted #Phenotypic #Analysis of #SARS-COV-2 #Omicron #Subvariants in Immunocompromised Patients with #COVID19 Following #Tixagevimab-Cilgavimab Prophylaxis https://www.sciencedirect.com/science/article/pii/S1386653223000057?dgcid=rss_sd_all